Effectiveness and Safety of High‐Dose Biologics in Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness and Safety of High‐Dose Biologics in Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance

Published:2021-06-13 Issue: Volume: Page:
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Correll Colleen K.¹^ORCID,Shrader Peter²,Dennos Anne²,Phillips Thomas²,Shiff Natalie J.³^ORCID,Verstegen Ruud H.J.⁴^ORCID,Beukelman Timothy⁵,

Affiliation:

1. Department of Pediatrics University of Minnesota Department of Pediatrics Minneapolis MN USA

2. Duke University Durham USA

3. Department of Community Health & Epidemiology University of Saskatchewan Saskatoon Saskatchewan Canada

4. Division of Clinical Pharmacology and Toxicology Department of Paediatrics The Hospital for Sick Children Toronto Ontario Canada

5. Department of Pediatrics University of Alabama at Birmingham Birmingham AL USA

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.24727

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trial;Pediatric Rheumatology;2024-05-10

2. Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis;Pharmacoepidemiology and Drug Safety;2024-04-29

3. Patterns and determinants of response to novel therapies in juvenile and adult-onset polyarthritis;Rheumatology;2023-09-19

4. Hochdosis-Biologikatherapie bei juveniler idiopathischer Arthritis;Aktuelle Rheumatologie;2023-04

5. Dosing Variation at Initiation of Adalimumab and Etanercept and Clinical Outcomes in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study;Arthritis Care & Research;2022-11-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3